Sep 10, 2026 · 15 min · 10 segments
Press Releases are an increasingly common method to learn about new/upcoming data. What can clinicians learn (and what can't we learn) from these? We read through two examples for just this purpose…
John BazarHost
And these are, I think, really designed for the biotech investors, some of whom actually listen to this podcast.

You've got to let the shareholders know, I guess, what's going on with the company they partially own as stockholders.

You know, when I started my career, if you wanted to use, you know, a new drug came out, you just wrote the orders.

Nowadays, you have to, you know, you have to have the treatment plan built and the electronic health record.

It's a little bit more cumbersome now just to start a new treatment plan for somebody.

So I've got two press releases I'm gonna go through today and then maybe a helpful tip if you have been dealing with drug shortages like you have.

And these are, I think, really designed for the biotech investors, some of whom actually listen to this podcast.

You've got to let the shareholders know, I guess, what's going on with the company they partially own as stockholders.

You know, when I started my career, if you wanted to use, you know, a new drug came out, you just wrote the orders.

Nowadays, you have to, you know, you have to have the treatment plan built and the electronic health record.

It's a little bit more cumbersome now just to start a new treatment plan for somebody.

So I've got two press releases I'm gonna go through today and then maybe a helpful tip if you have been dealing with drug shortages like you have.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.